Top 10 Pharmaceutical Technology Videos of 2025
Looking back at the top 10 PharmTech videos from 2025, we can see a clear focus on the pharmaceutical industry’s advancements in complex therapeutic modalities, regulatory environments, and technological integration. The videos shed light on specialized medicines like gene therapies, high-concentration biologics, and radiopharmaceuticals for cancer treatment. To support these advanced therapies, innovative manufacturing strategies such as “CGT 2.0” are being embraced, emphasizing flexibility, scalability, automation, and data analytics to ensure successful commercialization.
Quality systems, regulatory compliance, and digital transformation are vital components of these advancements. The industry is grappling with common regulatory challenges, responding to FDA warning letters, and ensuring drug safety through rigorous studies. Additionally, artificial intelligence (AI) and machine learning are being leveraged to optimize workflows, improve manufacturing controls, and hasten drug discovery. The industry’s focus on merging biological science with data technology reflects a drive towards faster, safer, and more personalized medicine in 2025.
Let’s delve deeper into some of the standout videos of 2025:
1. **Behind the Headlines Episode 24:** This video delves into the latest trends in the pharmaceutical industry, discussing mega-deals, big pharma patent cliffs, and the acquisition of diverse technological expertise for manufacturing advanced therapy medicinal products. Major acquisitions like AbbVie’s purchase of Bretisilocin and the collaboration between Enlaza Therapeutics and Vertex Pharmaceuticals were highlighted, along with the $17.5 billion Waters-Becton Dickinson deal.
2. **Advancing Radiopharmaceutical Development:** In an interview, Juliana Maynard, PhD, from Medicines Discovery Catapult, sheds light on the uniqueness of radiopharmaceuticals and challenges faced in their development. Radiopharmaceuticals offer precision in cancer treatment by targeting radiation directly to tumors, reducing side effects on healthy tissue. However, securing a global supply of radioisotopes, complying with stringent regulations, and managing logistics pose hurdles.
3. **PharmTech Weekly News Roundup – Week of September 29, 2025:** This roundup covers news on AI in drug development, FDA/EMA guidance, clinical advances, MFN pricing agreements, and quality control challenges. Topics such as patient perspectives in regulatory decisions, clinical trial progress, and FDA approvals were discussed.
4. **Drug Digest: Patient Preference Drives Solid Dosage Trends:** Lonza’s Adi Kaushal discusses the driving force behind trends in oral solid dosage formulation – patient preference. Contract development organizations play a crucial role in improving OSD bioavailability.
5. **PDA Regulatory Conference 2025: Wrap Up:** Susan J. Schniepp, Glenn Wright, and Melissa Seymour wrap up the PDA Regulatory Conference, focusing on quality culture, import alerts, artificial intelligence, and transparency. The topic of complete response letters garnered substantial interest.
These videos underscore the industry’s dedication to driving innovation, ensuring regulatory compliance, and integrating cutting-edge technology to deliver breakthrough therapies and personalized medicine to patients. 2025 has been a year of significant progress and challenges for the pharmaceutical sector, setting the stage for further advancements in the years to come.